PAEDIATRICS: Level 3 and Level 4 devices for diagnosis of sleep disordered breathing in children with neurodisability: considerations, challenges and comparisons with PSG
Tracks
Track 2
| Thursday, October 9, 2025 |
| 3:30 PM - 5:00 PM |
Details
This symposium will discuss alternatives to in lab level 1 PSG for children with neurodisability who are one of the largest sub-populations of children who undergo evaluation for SDB in tertiary centres. Comparison data from clinical trials and pilot studies undertaken with level 2 and 3 devices will be presented, focusing on the specific benefits and challenges with these devices in children with neurodisability.
Speaker
Adelaide Withers
Comparison with level 1 PSG: Home level 2 PSG for the diagnosis of sleep disordered breathing in children with neurodisability
3:30 PM - 3:47 PMBiography
Anne-Marie Adams
Level 3 and level 4 devices for diagnosis of SDB in children - what's available and what's the evidence in children?
3:47 PM - 4:04 PMBiography
Moya Vandeleur
Royal Children's Hospital Melbourne
Pros and cons of level 3 and 4 devices in children with neurodisability, including consumer perspectives
4:04 PM - 4:21 PMBiography
Andrew Collaro
Comparison with level 1 PSG: (1) Machine-learning pulse oximetry analysis and (2) mandibular movement monitoring for the detection of SDB in children with neurodisability
4:21 PM - 4:38 PMBiography
Jasneek Chawla
Queensland Children’s Hospital
Comparison with level 1 PSG: Results of an Australian multi-centre clinical trial of the Sonomat Sleep Mat System for diagnosis of SDB in children with neurodisability
4:38 PM - 4:55 PMBiography
Karen Waters
Chair
Biography
Dr Ajay Kevat
Senior Medical Officer
Queensland Children's Hospital
Chair
Biography
